Trials / Completed
CompletedNCT00467441
VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Efficacy and Safety of VSF-173 and Matching Placebo in Healthy Male and Female Subjects With Induced Excessive Sleepiness
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety and efficacy of VSF-173 compared to placebo in treatment of induced excessive sleepiness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VSF-173 |
Timeline
- First posted
- 2007-04-30
- Last updated
- 2007-11-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00467441. Inclusion in this directory is not an endorsement.